Annual Cash & Cash Equivalents
$4.32 M
-$1.85 M-30.02%
December 31, 2023
Summary
- As of February 8, 2025, WINT annual cash & cash equivalents is $4.32 million, with the most recent change of -$1.85 million (-30.02%) on December 31, 2023.
- During the last 3 years, WINT annual cash & cash equivalents has fallen by -$12.61 million (-74.49%).
- WINT annual cash & cash equivalents is now -94.99% below its all-time high of $86.28 million, reached on December 31, 2013.
Performance
WINT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.30 M
+$497.00 K+27.57%
September 30, 2024
Summary
- As of February 8, 2025, WINT quarterly cash and cash equivalents is $2.30 million, with the most recent change of +$497.00 thousand (+27.57%) on September 30, 2024.
- Over the past year, WINT quarterly cash and cash equivalents has dropped by -$5.07 million (-68.77%).
- WINT quarterly cash and cash equivalents is now -97.33% below its all-time high of $86.28 million, reached on December 31, 2013.
Performance
WINT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WINT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.0% | -68.8% |
| 3 y3 years | -74.5% | -45.7% |
| 5 y5 years | -61.4% | -45.7% |
WINT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.7% | at low | -89.7% | +27.6% |
| 5 y | 5-year | -80.9% | at low | -94.0% | +27.6% |
| alltime | all time | -95.0% | +2059.5% | -97.3% | +2200.0% |
Windtree Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.30 M(+27.6%) |
| Jun 2024 | - | $1.80 M(-29.2%) |
| Mar 2024 | - | $2.55 M(-41.0%) |
| Dec 2023 | $4.32 M(-30.0%) | $4.32 M(-41.4%) |
| Sep 2023 | - | $7.37 M(-35.8%) |
| Jun 2023 | - | $11.47 M(+170.8%) |
| Mar 2023 | - | $4.24 M(-31.4%) |
| Dec 2022 | $6.17 M(-72.4%) | $6.17 M(-26.8%) |
| Sep 2022 | - | $8.44 M(-25.9%) |
| Jun 2022 | - | $11.38 M(-26.8%) |
| Mar 2022 | - | $15.54 M(-30.5%) |
| Dec 2021 | $22.35 M(+32.0%) | $22.35 M(-8.9%) |
| Sep 2021 | - | $24.54 M(-18.1%) |
| Jun 2021 | - | $29.96 M(-22.1%) |
| Mar 2021 | - | $38.49 M(+127.3%) |
| Dec 2020 | $16.93 M(-25.0%) | $16.93 M(-24.3%) |
| Sep 2020 | - | $22.36 M(-29.1%) |
| Jun 2020 | - | $31.52 M(+87.6%) |
| Mar 2020 | - | $16.80 M(-25.6%) |
| Dec 2019 | $22.58 M(+101.8%) | $22.58 M(+408.9%) |
| Sep 2019 | - | $4.44 M(-27.5%) |
| Jun 2019 | - | $6.12 M(+198.3%) |
| Mar 2019 | - | $2.05 M(-81.6%) |
| Dec 2018 | $11.19 M(+516.4%) | $11.19 M(+1648.0%) |
| Sep 2018 | - | $640.00 K(+0.3%) |
| Jun 2018 | - | $638.00 K(-65.6%) |
| Mar 2018 | - | $1.85 M(+2.1%) |
| Dec 2017 | $1.81 M(-67.5%) | $1.81 M(+3.6%) |
| Sep 2017 | - | $1.75 M(-30.7%) |
| Jun 2017 | - | $2.53 M(-68.5%) |
| Mar 2017 | - | $8.02 M(+43.6%) |
| Dec 2016 | $5.59 M(-85.6%) | $5.59 M(-54.9%) |
| Sep 2016 | - | $12.38 M(-39.1%) |
| Jun 2016 | - | $20.33 M(-30.9%) |
| Mar 2016 | - | $29.40 M(-24.1%) |
| Dec 2015 | $38.72 M(-13.4%) | $38.72 M(-16.4%) |
| Sep 2015 | - | $46.31 M(+77.5%) |
| Jun 2015 | - | $26.09 M(-26.7%) |
| Mar 2015 | - | $35.58 M(-20.4%) |
| Dec 2014 | $44.71 M(-48.2%) | $44.71 M(-18.6%) |
| Sep 2014 | - | $54.91 M(-16.2%) |
| Jun 2014 | - | $65.56 M(-13.7%) |
| Mar 2014 | - | $75.94 M(-12.0%) |
| Dec 2013 | $86.28 M(+220.9%) | $86.28 M(+307.4%) |
| Sep 2013 | - | $21.18 M(-32.2%) |
| Jun 2013 | - | $31.25 M(+18.5%) |
| Mar 2013 | - | $26.37 M(-1.9%) |
| Dec 2012 | $26.89 M(+163.9%) | $26.89 M(-25.4%) |
| Sep 2012 | - | $36.06 M(-21.6%) |
| Jun 2012 | - | $46.01 M(-16.0%) |
| Mar 2012 | - | $54.80 M(+437.9%) |
| Dec 2011 | $10.19 M(-0.2%) | $10.19 M(-33.9%) |
| Sep 2011 | - | $15.41 M(-28.5%) |
| Jun 2011 | - | $21.54 M(-22.1%) |
| Mar 2011 | - | $27.66 M(+170.9%) |
| Dec 2010 | $10.21 M | $10.21 M(-30.3%) |
| Sep 2010 | - | $14.65 M(-37.2%) |
| Jun 2010 | - | $23.32 M(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $24.17 M(+53.6%) |
| Dec 2009 | $15.74 M(-30.8%) | $15.74 M(-11.0%) |
| Sep 2009 | - | $17.68 M(-24.4%) |
| Jun 2009 | - | $23.38 M(+22.2%) |
| Mar 2009 | - | $19.13 M(-15.9%) |
| Dec 2008 | $22.74 M(-38.4%) | $22.74 M(-15.5%) |
| Sep 2008 | - | $26.93 M(-1.5%) |
| Jun 2008 | - | $27.34 M(+43.5%) |
| Mar 2008 | - | $19.05 M(-48.4%) |
| Dec 2007 | $36.93 M(+39.9%) | $36.93 M(+96.1%) |
| Sep 2007 | - | $18.83 M(-12.4%) |
| Jun 2007 | - | $21.50 M(+18.9%) |
| Mar 2007 | - | $18.08 M(-31.5%) |
| Dec 2006 | $26.40 M(-43.8%) | $26.40 M(+39.7%) |
| Sep 2006 | - | $18.89 M(-29.0%) |
| Jun 2006 | - | $26.63 M(-17.4%) |
| Mar 2006 | - | $32.23 M(-31.4%) |
| Dec 2005 | $47.01 M(+60.6%) | $47.01 M(+14.0%) |
| Sep 2005 | - | $41.25 M(+138.0%) |
| Jun 2005 | - | $17.34 M(-40.1%) |
| Mar 2005 | - | $28.96 M(-1.0%) |
| Dec 2004 | $29.26 M(-0.5%) | $29.26 M(+32.1%) |
| Sep 2004 | - | $22.16 M(-5.8%) |
| Jun 2004 | - | $23.53 M(-0.2%) |
| Mar 2004 | - | $23.56 M(-19.9%) |
| Dec 2003 | $29.42 M(+244.6%) | $29.42 M(-9.8%) |
| Sep 2003 | - | $32.61 M(+4.5%) |
| Jun 2003 | - | $31.21 M(+353.4%) |
| Mar 2003 | - | $6.88 M(-19.4%) |
| Dec 2002 | $8.54 M(+127.2%) | $8.54 M(+151.0%) |
| Sep 2002 | - | $3.40 M(+17.3%) |
| Jun 2002 | - | $2.90 M(-47.4%) |
| Mar 2002 | - | $5.51 M(+46.8%) |
| Dec 2001 | $3.76 M(-48.4%) | $3.76 M(+19.8%) |
| Sep 2001 | - | $3.14 M(-16.9%) |
| Jun 2001 | - | $3.77 M(+315.4%) |
| Mar 2001 | - | $908.00 K(-87.5%) |
| Dec 2000 | $7.28 M(+105.3%) | $7.28 M(-23.9%) |
| Sep 2000 | - | $9.57 M(-19.0%) |
| Jun 2000 | - | $11.81 M(-49.9%) |
| Mar 2000 | - | $23.59 M(+565.1%) |
| Dec 1999 | $3.55 M(+136.5%) | $3.55 M(+108.6%) |
| Sep 1999 | - | $1.70 M(+142.9%) |
| Jun 1999 | - | $700.00 K(-30.0%) |
| Mar 1999 | - | $1.00 M(-33.3%) |
| Dec 1998 | $1.50 M(-76.2%) | $1.50 M(-44.4%) |
| Sep 1998 | - | $2.70 M(-20.6%) |
| Jun 1998 | - | $3.40 M(-42.4%) |
| Mar 1998 | - | $5.90 M(-6.3%) |
| Dec 1997 | $6.30 M(+3050.0%) | $6.30 M(+2000.0%) |
| Sep 1997 | - | $300.00 K(-40.0%) |
| Jun 1997 | - | $500.00 K(-58.3%) |
| Mar 1997 | - | $1.20 M(+500.0%) |
| Dec 1996 | $200.00 K | $200.00 K(+100.0%) |
| Sep 1996 | - | $100.00 K(0.0%) |
| Jun 1996 | - | $100.00 K(0.0%) |
| Mar 1996 | - | $100.00 K(-80.0%) |
| Jun 1995 | - | $500.00 K |
FAQ
- What is Windtree Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Windtree Therapeutics?
- What is Windtree Therapeutics annual cash & cash equivalents year-on-year change?
- What is Windtree Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Windtree Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of WINT is $4.32 M
What is the all time high annual cash & cash equivalents for Windtree Therapeutics?
Windtree Therapeutics all-time high annual cash & cash equivalents is $86.28 M
What is Windtree Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, WINT annual cash & cash equivalents has changed by -$1.85 M (-30.02%)
What is Windtree Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of WINT is $2.30 M
What is the all time high quarterly cash and cash equivalents for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly cash and cash equivalents is $86.28 M
What is Windtree Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, WINT quarterly cash and cash equivalents has changed by -$5.07 M (-68.77%)